N20
Conditions
Interventions
Group 1: Uncoated ureteral stent
Group 2: Coated ureteral stent
Sponsors
UroNova GmbH medizinische Implantate
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with renal colic that cannot be controlled with medication, severe obstruction with consecutive urinary congestion and / or increasing retention values ??in accordance with the S2k guideline for diagnosis, therapy and metaphylaxis of urolithiasis. After complicated procedures using ureterorenoscopy, in the case of residual fragments or complications that require treatment In the case of Steinstrasse and fever / urinary tract infection (accumulation of stone fragments in the ureter, which do not pass spontaneously and / or block urine transport) Age:> 18 years Written declaration of consent available
Exclusion criteria
Exclusion criteria: Patients for whom a ureteral stent cannot be used due to the anatomical conditions. Insufficient mental, linguistic, or physical ability to participate in the study. ECOG> 3 (Eastern Co-operative of Oncology Group) Refusal to participate in the clinical trial. Planned long-term supply or foreseeable long indwelling time of the ureteral stent (> 30 days). Participation in another clinical trial within the last 30 days. Patients who are pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of the weight of encrustation after 30 days indwelling time | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the grade of ureteral stent symptoms 7 days after insertion and 7 days after removal | — |
Countries
Germany
Contacts
Public ContactSascha Pahernik
Urological Clinic, Klinikum Nürnberg
Outcome results
None listed